IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v434y2005i7030d10.1038_nature03308.html
   My bibliography  Save this article

Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors

Author

Listed:
  • Akinori Takaoka

    (University of Tokyo)

  • Hideyuki Yanai

    (University of Tokyo)

  • Seiji Kondo

    (University of Toronto)

  • Gordon Duncan

    (University of Toronto)

  • Hideo Negishi

    (University of Tokyo)

  • Tatsuaki Mizutani

    (University of Tokyo)

  • Shin-ichi Kano

    (University of Tokyo)

  • Kenya Honda

    (University of Tokyo)

  • Yusuke Ohba

    (University of Tokyo
    Information and Cell Function, PRESTO, JST)

  • Tak W. Mak

    (University of Toronto)

  • Tadatsugu Taniguchi

    (University of Tokyo)

Abstract

The activation of Toll-like receptors (TLRs) is central to innate and adaptive immunity1,2,3. All TLRs use the adaptor MyD88 for signalling4, but the mechanisms underlying the MyD88-mediated gene induction programme are as yet not fully understood. Here, we demonstrate that the transcription factor IRF-5 is generally involved downstream of the TLR–MyD88 signalling pathway for gene induction of proinflammatory cytokines, such as interleukin-6 (IL-6), IL-12 and tumour-necrosis factor-α. In haematopoietic cells from mice deficient in the Irf5 gene (Irf5-/- mice), the induction of these cytokines by various TLR ligands is severely impaired, whereas interferon-α induction is normal. We also provide evidence that IRF-5 interacts with and is activated by MyD88 and TRAF6, and that TLR activation results in the nuclear translocation of IRF-5 to activate cytokine gene transcription. Consistently, Irf5-/- mice show resistance to lethal shock induced by either unmethylated DNA or lipopolysaccharide, which correlates with a marked decrease in the serum levels of proinflammatory cytokines. Thus, our study identifies IRF-5 as a new, principal downstream regulator of the TLR–MyD88 signalling pathway and a potential target of therapeutic intervention to control harmful immune responses.

Suggested Citation

  • Akinori Takaoka & Hideyuki Yanai & Seiji Kondo & Gordon Duncan & Hideo Negishi & Tatsuaki Mizutani & Shin-ichi Kano & Kenya Honda & Yusuke Ohba & Tak W. Mak & Tadatsugu Taniguchi, 2005. "Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors," Nature, Nature, vol. 434(7030), pages 243-249, March.
  • Handle: RePEc:nat:nature:v:434:y:2005:i:7030:d:10.1038_nature03308
    DOI: 10.1038/nature03308
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature03308
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/nature03308?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Zhao Wang & Qian Liang & Xinyi Qian & Bolang Hu & Zhanye Zheng & Jianhua Wang & Yuelin Hu & Zhengkai Bao & Ke Zhao & Yao Zhou & Xiangling Feng & Xianfu Yi & Jin Li & Jiandang Shi & Zhe Liu & Jihui Hao, 2023. "An autoimmune pleiotropic SNP modulates IRF5 alternative promoter usage through ZBTB3-mediated chromatin looping," Nature Communications, Nature, vol. 14(1), pages 1-23, December.
    2. Fan Li & Hui Wang & Yan-Qi Li & Yebo Gu & Xin-Ming Jia, 2023. "C-type lectin receptor 2d forms homodimers and heterodimers with TLR2 to negatively regulate IRF5-mediated antifungal immunity," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    3. Grigory Ryzhakov & Hannah Almuttaqi & Alastair L. Corbin & Dorothée L. Berthold & Tariq Khoyratty & Hayley L. Eames & Samuel Bullers & Claire Pearson & Zhichao Ai & Kristina Zec & Sarah Bonham & Roman, 2021. "Defactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal inflammation," Nature Communications, Nature, vol. 12(1), pages 1-15, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:434:y:2005:i:7030:d:10.1038_nature03308. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.